The codelivery of sirna and qds by ph-responsive micelle for hepatoma cancer cells

11Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Recently, RNA interfering (RNAi) has become a promising approach for cancer therapy. However, the application of RNAi for clinics is still hindered due to the lack of safe and effcient carriers. In this study, a pH-responsive micelle based on polycaprolactoneblock-poly 2-(dimethylamino)ethyl methacrylate (PCL-PDEM) cationic copolymer was developed to carry short interfering RNA (siRNA) for silencing interleukin 8 (IL-8) gene in hepatoma cancer cells. The transfection effciency of the PCL-PDEM-siRNA/quantum dots (QDs) nanoplex has reached about 70%, and the expression level of IL-8 decreased about 63%. Furthermore, the codelivery of QDs and siRNA has been realized, which is benefcial to visualize the process of siRNA delivery. No considerable cytotoxicity from the nanoparticles has been observed, indicating that our responsive cationic micelle is potential in clinical trial for hepatoma cancer therapy.

Cite

CITATION STYLE

APA

Cao, Z., Xiao, H., Li, L., Liu, M., Lin, G., Zhai, P., … Xu, G. (2019). The codelivery of sirna and qds by ph-responsive micelle for hepatoma cancer cells. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.01194

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free